Reduced relapse rate in upfront tandem autologous/reduced intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression free and not of overall survival.

Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJose', van Oers M, Raymakers R, Minnema MC, Zweegman S, Bos G, Schaap N, et al. Reduced relapse rate in upfront tandem autologous/reduced intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression free and not of overall survival. Haematologica. 2015.